Cipla is currently trading at Rs. 533.20, up by 5.25 points or 0.99% from its previous closing of Rs. 527.95 on the BSE.
The scrip opened at Rs. 536.00 and has touched a high and low of Rs. 546.00 and Rs. 528.00 respectively. So far 119940 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 678.00 on 19-Sep-2018 and a 52 week low of Rs. 483.75 on 29-Jan-2019.
Last one week high and low of the scrip stood at Rs. 546.00 and Rs. 501.25 respectively. The current market cap of the company is Rs. 43060.34 crore.
The promoters holding in the company stood at 36.70%, while Institutions and Non-Institutions held 39.60% and 23.69% respectively.
Cipla has reported a fall of 29.44% in its net profit at Rs 295.32 crore for the quarter ended December 31, 2018 as compared to Rs 418.54 crore for the same quarter in the previous year. Total income of the decreased by 3.28% at Rs 2912.15 crore for Q3FY19 as compared Rs 3010.89 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 17.06% in its net profit at Rs 332.20 crore for the quarter under review as compared to Rs 400.51 crore for the same quarter in the previous year. However, total income of the company increased by 3.01% at Rs 4086.07 crore for Q3FY19 as compared Rs 3966.75 crore for the corresponding quarter previous year.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.80 |
| Dr. Reddys Lab | 1238.00 |
| Cipla | 1238.25 |
| Zydus Lifesciences | 942.95 |
| Lupin | 2333.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: